Quest Diagnostics Incorporated (DGX)

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock

Quest Diagnostics Incorporated $DGX Stock Holdings Lifted by Eastern Bank

Dividend Champion, Contender, And Challenger Highlights: Week October 4

Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials

Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare Headwinds

Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026

Why Quest Diagnostics Holdings Stock Dropped Today

Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure

Is This the Right Time to Add DGX Stock to Your Portfolio?

Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges

Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges

Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics

Corient Private Wealth LP Sells 5,233 Shares of Quest Diagnostics Incorporated $DGX

Fed Hikes Interest Rates, Signals Another: 4 Low-Beta Defensive Picks

Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?

Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics

Quest Diagnostics (NYSE:DGX) Reaches New 52-Week High – Time to Buy?

Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript